Final Programme - iuphar

FC01 Clinical pharmacology in the emerging countries
Mon 032 Pharmacokinetic study of recombinant humanized anti-VEGF monoclonal antibody (Bevacizumab) in
Chinese subjects with advanced malignancies
Yang Li, (PR China), X Hu, G Cheng, YL Nie, YB Zhao, JY Wu, KX Li, C Qi
Mon 033 Pharmacokinetics and pharmacodynamics of pegylated interferon-α2a in healthy male volunteers
Lay Ahyoung Lim, (South Korea), H Son, S Jang, Y Lee, JY Chung, K Park
Mon 034 Discovery of novel influenza neuraminidase inhibitors from natural products
Ailin Liu, (PR China), S Lee, Y Wang, G Du
Mon 035 Disruption of BBB in rat MCAO and a protective effect of anti-HMGB1 antibody
Keyue Liu, (Japan), J Zhang, HK Takahashi, Y Tomono, H Wake, T Maruo, A Otsuka, S Mori,
M Nishibori
Mon 036 Evaluation of the effect of increasing hydration to premedication treatments of chemotherapy with
cisplatin in decreasing renal side effects of it in patients of Air force and Buali hospitals in Tehran from
2007 to 2009
Artin Mardirosian, (Iran), MH Lashkari, F Nejad Dadgar, H Molana, M Fotouhi
Mon 037 The attitude of medical students towards traditional medicine
Ortrun Meissner-Kirch, (South Africa), EN Kwizera
Mon 038 Safety and efficacy of granulocyte colony-stimulating factor (ior-LeukoCIM) in oncohematology patients.
Phase IV
Ivis Cristina Mendoza Hernandez, (Cuba), EG Lopez, MW de Leon, AM Veitia, JDF Aguila, EV Olazabal,
MR Garcia, PP Sierra, GS Martinez, Y Barrese Pérez
Mon 039 Clinical pharmacology service rationalized use of costly drug in academic hospital of a country in
socio-economic transition
Dragan Milovanovic, (Republic of Serbia), S Jankovic, D Ruzic Zecevic
162 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area